Fate Therapeutics logo
Fate Therapeutics
FATE | NASDAQ
Chart Builder DCF Calculator
$1.14
-$0.14 (-10.94%)
At close: Nov 16, 2026, 4:00 PM ET
$1.14
$0.00 (0.00%)
Pre-market: Nov 17, 2026, 4:53 AM ET

Fate Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-30.69M -30.16M -31.21M -32.37M -32.25M -34.07M -37.62M -52.15M -47.68M -38.43M -48M -44.12M -45.17M -52.76M -18.88M -56.36M -83.56M -76.11M -65.69M -68.62M -43.31M -55.13M -45.09M
2.68M 2.78M 2.92M 3.06M 3.23M 3.28M 3.33M 4.81M 4.61M 4.72M 4.82M 4.89M 4.74M 4.47M 4.19M 4.84M 3.19M 2.96M 2.76M 2.21M 1.52M 1.17M 959K
2.7M 3.52M 3.93M 5.53M 4.86M 7.15M 7.38M 9.12M 11.77M 9.63M 10.98M – 10.1M – 10.98M – 19.47M 20.54M 19.33M 14.59M 13.54M 13.25M 12.98M
-1.81M -1.32M -402K 1.29M -209K -937K -6.51M -2.5M 3.74M -3.6M -354K 1.99M -4.12M 3.75M 7.57M -7.68M -3.06M -1.89M -2.46M -11.5M 6.28M 2.9M 7.58M
-872K 491K -492K -586K -716K -1.02M -1.53M 12.33M -1.24M -4.44M -1.76M 2.79M -5.13M 9.76M -37.31M 8.68M -4.27M 603K -9.89M -5.61M -14.4M 9.07M -2.09M
– – – – – – – – – – – – – – – – – – – – – – –
-1.71M -64K -5.96M 1.06M 504K 73K -5.37M -1.91M 3.13M -3.79M 614K -189K -2.82M 10.04M 12.15M -32.55M 10.12M -1.16M -11.13M -12.87M 9.28M -460K 6.15M
-27.89M -23.43M -30.82M -23.31M -24.37M -24.59M -33.81M -27.8M -29.42M -32.31M -33.35M -36.64M -38.27M -28.49M -28.86M -75.39M -55.05M -53.16M -64.61M -70.29M -33.38M -32.11M -27.1M
– -80K -239K -1.19M -2.2M -1.36M -1.2M -98K -495K -51K -86K -181K -565K -2.2M -3.21M -6.68M -8.68M -10.13M -10.08M -18.37M -14.74M -13.62M -3.98M
– – – -122K – – – – – – – – – – – – – – – – – – –
-17.66M -58.35M -28.73M -37.73M -57.98M -50.81M -48.62M -38.01M -64.74M -128.67M -86.34M -49.97M -102.13M -92.26M -114.45M -107.1M -101.58M -63.95M -132.17M -173.45M -165.47M -99.34M -529.91M
44.5M 72.98M 52.56M 66.32M 81.45M 71.64M 92.49M 60.92M 90.7M 75.34M 103.74M 95.5M 127.5M 127.63M 127M 166.89M 190.63M 114.37M 135.22M 263.09M 258.16M 111.58M 62M
– – – 359K 3K 122K – – – – – – – – – – – – – – – – –
26.84M 14.56M 23.59M 27.63M 21.27M 19.59M 42.67M 22.82M 25.46M -53.37M 17.31M 45.35M 24.81M 33.17M 9.34M 53.11M 80.38M 40.29M -7.03M 71.28M 77.96M -1.37M -471.89M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– 1.32M – 1.69M 2.48M 1.33M – 3.13M – 1.94M 20.3M – – – – – – 3.41M – 3.45M 28.62M 3.72M 5.61M
7.62M 1.74M – 1.69M 2.48M 1.33M – 3.13M – 1.27M 95.49M -180K – 58K 207K 1.52M 1.49M 3.41M 2.8M 3.42M 7.94M 3.72M 438.05M
6.56M -7.14M -7.24M 6.01M -627K -3.67M 8.86M -1.85M 992K -84.41M 79.45M 8.54M -13.47M 4.78M -19.31M -20.76M 26.82M -9.47M -68.84M 4.4M 52.53M -29.76M -60.93M
-27.89M -23.51M -31.06M -24.51M -26.58M -25.95M -35.01M -27.9M -29.91M -32.36M -33.44M -36.82M -38.84M -30.69M -32.07M -82.07M -63.72M -63.29M -74.7M -88.66M -48.11M -45.73M -31.08M
-30.59M -27.03M -34.99M -30.03M -31.44M -33.1M -42.39M -37.02M -41.68M -41.99M -44.42M -36.82M -48.94M -30.69M -43.05M -82.07M -83.19M -83.83M -94.03M -103.26M -61.65M -58.98M -44.05M
– -80K -239K -1.19M -2.2M -1.36M -1.2M – – – -86K -181K -565K -2.2M – – -7.37M -1.22M – -15.32M – – –
– – – – – – – -98K -495K -51K – – – – -3.21M -6.68M -1.31M -8.9M -10.08M -3.05M -14.74M -13.62M -3.98M
-27.89M -23.51M -31.06M -24.51M -26.58M -25.95M -35.01M -27.8M -29.42M -32.31M -33.44M -36.82M -38.84M -30.69M -28.86M -75.39M -62.41M -54.38M -64.61M -85.61M -33.38M -32.11M -27.1M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.